ArticleERJ open research2026

Off-label treatment with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: real-world evidence from the German CF Registry.

Mirjam Stahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.